Home
Clinical Resources Search
PQI: DPYD Testing Prior to Fluoropyrimidine Treatment

DPYD Testing Prior to Fluoropyrimidine Treatment

Download PQI pdf

Last Updated: May 22, 2024

By: Dan Hertz, PharmD, PhD

About this PQI

The purpose of this PQI is to review recommendations for DPYD testing prior to initiation of treatment with fluoropyrimidine based chemotherapy and increase awareness of the clinical benefit of pretreatment DPYD testing.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

DPYD Testing Prior to Fluoropyrimidine Treatment

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer

PQI: Cardiovascular Risk associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer

PQI: Administration of Subcutaneous Isatuximab-irfc (SARCLISA ESCENA) via the CirCLIQ On-Body Delivery System

PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E8: The Future of Oncology

S11 E9: Fungi, Facts, and Cancer Care: Exploring Medicinal Mushrooms

S11 E6: Finding the Heart of Oncology

S11 E7: Your Health Story in One Place

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Zanidatamab-hrii

Treatment Support Kit: Avutometinib and Defactinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Irinotecan

S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

PQI in Action: Larotrectinib (Vitrakvi) Overview

PQI Podcast S6 Ep 9: ctDNA Testing in GI Cancers

PQI Podcast S6 Ep 2: Molecular Testing & Targeted Treatment in Colorectal Cancer

PQI: Selpercatinib (Retevmo®) Genomic Testing Management

Pembrolizumab, Trastuzumab, and CAPOX

Trastuzumab, Capecitabine, and Cisplatin

Pembrolizumab, Trastuzumab, Capecitabine, and Cisplatin

Capecitabine and Oxaliplatin with Radiation Therapy

Zolbetuximab and FOLFOX

Atezolizumab and FOLFOX

Liposomal Irinotecan, Leucovorin, Fluorouracil and Oxaliplatin

Liposomal Irinotecan, Fluorouracil and Leucovorin